DATA
VISIT DATA
Here are the gold-standard databases and data visualizations of R&D funding, approved products and candidates in the pipeline for neglected diseases, emerging infectious diseases and maternal health.
Our data portals
G-FINDER R&D funding portal
Since 2007, the G-FINDER project tracks R&D funding for new products and technologies across global health areas.
Product pipeline portal
Our product pipeline portal provides an overview of health products approved or in development across global health areas.
Innovation Spillover Tracker
A tracker of health innovations developed for LMICs that have translated into new applications and benefits in HICs.
INSIGHTS
VISIT INSIGHTS
Here you will find the analysis and insights to support decisions - whether you're funding research, setting policies, developing products or advocating for change.
Explore our hubs
The Investment Landscape Hub
A unique source of data and analysis tracking the funding of global health R&D and the pipeline of products in development. Powered by G-FINDER.
The Impact of Global Health R&D Hub
Global, UK and EU analyses of the health and economic impact of the last two decades of investment in global health R&D.
Women's Health Hub
This resource hub provides a suite of data, insights and tools to accelerate progress in women’s health R&D
Report Library
Our reports deliver critical insights using the evidence collected through G-FINDER and over two decades of independent analysis.
Health areas
This quick reference guide gives you a snapshot analysis of the R&D needs and the state of innovation to tackle each disease or condition we cover. It's a handy quick overview of what's needed to impact global health in these areas.
Hubs
Themed collections of all the data, analysis and tools you need to understand the landscape and make smart decisions on global health R&D.
Impact Global Health and PATH R&D Blindspots Policy Series
PATH and Impact Global Health are joining forces to provide decision-makers with clarity and evidence on critical global health choices, with a focus on Africa.
TOOLS
VISIT TOOLS
We've created some practical frameworks and tools you can use to assess and increase impact in global health.
Advocacy Kits
Join us in creating global health impact with our advocacy and press kits
Impact Framework
A global network of experts collaborated for two years to develop this comprehensive set of metrics that create an impact assessment framework for global health R&D.
100 Days Mission Scorecard
Is the world ready to deploy a new product to tackle an epidemic within 100 days of an outbreak?
ABOUT US
VISIT ABOUT US
Meet the team working to create a more equitable future through global health innovation and impact.
Our Team
Meet our diverse international team of experts, who collate and analyse data on global health funding and the innovation pipeline
Our Global Advisory Council
Bringing together some of the leading and most influential figures in global health, our Council challenges our thinking, expands our foresight and helps us with horizon scanning
Join Us
We build bridges, partnerships and consensus across the complex ecosystem of global health R&D players. Find out how to partner with us, commission our expertise, and how to join our team when we have vacancies.
Contact Us
Please get in touch with any questions or feedback. Between us, we cover most time zones so one of us will get back to you quickly.
Advocacy Kits
Join us in creating global health impact with our advocacy and press kits
NEWS

Research Assistant

Negar Zareei

Australia

About

Master of Pharmaceutical Science

Negar has a background in Medical Laboratory Science and holds a Master of Pharmaceutical Science with Distinction from Monash University. Her research interests span pharmaceutical R&D and translational medicine. Alongside her doctoral research training at Macquarie University focused on drug delivery strategies for Alzheimer’s disease, Negar works as a Research Assistant on the G-FINDER project at Impact Global Health, where she contributes to the analysis and classification of global funding for neglected disease and emerging infectious disease R&D.

Negar Zareei

About

Share